Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,243 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06738329Recruiting
How seaweed additive carrageenan affects gut bacteria
This study tests whether carrageenan, a seaweed-based food ingredient, changes the balance of bacteria in your gut. It could help us understand how common food additives affect digestion and overall health.
Reading, ReadingAges 18–55 - NCT02653001Enrolling by invitation
Testing samples in healthy people near Norwich Research Park
This study collects bowel-related samples from healthy people to help researchers test a “colon model” in the lab. You may be eligible if you live or work close by and you don’t have ongoing stomach/bowel conditions or recent major changes.
Norwich, NorfolkAges 18 years+ - NCT06880419RecruitingPhase 2
Anti-CD25 antibody to prevent graft-versus-host disease in high-risk adults
This trial tests whether an antibody called anti-CD25 can help prevent a serious side effect (graft-versus-host disease) in adults getting a stem cell transplant for blood disorders. It is for people considered high-risk based on a special scoring model.
Tianjin, Tianjin MunicipalityAges 16 years+ - NCT06820151Enrolling by invitation
Exploring injury and repair in the human esophagus
This study looks at how the esophagus heals after injury or surgery. It may help doctors find better ways to prevent or treat leaks that can happen after certain upper gastrointestinal procedures.
CambridgeAges 18–99 - NCT07262164RecruitingPhase 1
Testing VG2062 for advanced solid tumors
This trial is testing a new drug called VG2062 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how the body processes it.
HebeiAges 18–75 - NCT07249489Recruiting
New implant for knee cartilage repair
This study tests a new type of implant designed to repair damaged knee cartilage. It may be an option for people with a knee injury who are generally healthy and not taking certain medications.
Vancouver, British ColumbiaAges 22–60 - NCT06219018RecruitingPhase 1/Phase 2
Testing honey for moderate cervical cell changes
This study tests whether honey applied directly to the cervix can help reverse moderate cervical cell changes (CIN II). It may offer a natural alternative to more invasive procedures.
Heerlen, LimburgAges 18–40 - NCT06886048Recruiting
Barley Green for Reducing Belly Fat
This trial tests whether barley green can help reduce deep belly fat (visceral fat). Participants take barley green supplements while researchers check for changes in fat and gut bacteria. It may be an option if you have excess abdominal fat and are not taking certain medications.
Beijing, Xicheng DistrictAges 18–65 - NCT06554795RecruitingPhase 1/Phase 2
Testing DB-1419 for advanced solid tumors
This trial tests a new drug called DB-1419 for people with advanced solid tumors that have not responded to other treatments. It is designed to target a protein called B7-H3 on cancer cells, and may help shrink tumors or slow their growth.
Los Angeles, CaliforniaAges 18 years+ - NCT06691932Recruiting
Breastfeeding vs. Pumped Milk: Infant Nutrition Study
This study compares the health and development of babies who feed directly at the breast versus those who get pumped breast milk. It aims to understand how different ways of feeding human milk affect infant nutrition and growth.
Rochester, New YorkAges birth–40 years - NCT06808776Recruiting
Stories to prevent HPV cancers
This trial tests if sharing stories can help parents decide to get their child the HPV vaccine. It is for parents of children ages 9 to 12 who have not yet started the HPV shot series.
Hershey, PennsylvaniaAges 18 years+ - NCT06628193Enrolling by invitation
Ultrasound effects on human memory study
This study uses low-intensity focused ultrasound to see how it affects memory. It may help researchers understand how to improve memory or treat conditions that affect it.
Roanoke, VirginiaAges 18–65 - NCT07321028Enrolling by invitationEarly Phase 1
Study of freezing methods on human cell samples
This study tests different freezing methods on human cell samples to see which work best. It does not involve human volunteers, only donated cells that have been de-identified.
New York, New YorkAges Any age - NCT07136779RecruitingPhase 1/Phase 2
Study of VBC101 for advanced solid tumors
This trial tests a new drug called VBC101 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if VBC101 is safe and effective.
Grand Rapids, MichiganAges 18 years+ - NCT06650956Recruiting
HPV vaccine and health education for teens in Laos
This trial offers HPV vaccination and sexual health education to 10-13 year old students and out-of-school youth in Laos. It aims to improve health knowledge and vaccination rates.
Muang Sing, ProvinceAges 10–13 - NCT07413939RecruitingPhase 2/Phase 3
Study of RO7771950 vs tucatinib for HER2-positive breast cancer
This trial tests a new drug, RO7771950, against another drug called tucatinib. Both are given with standard chemotherapy to see which works better for advanced breast cancer that is HER2-positive. People with brain metastases may join.
Germantown, TennesseeAges 18 years+ - NCT06942195Recruiting
Calcium's effect on gut function and blood sugar in type 2 diabetes
This study tests if calcium can help control blood sugar and gut function in men with type 2 diabetes. You'll take calcium or a placebo and have a tube inserted into your stomach to measure digestion.
Adelaide, South AustraliaAges 18–70 - NCT06622681Recruiting
Adolescent health and development research study
This study follows teenagers to understand their health, growth, and well-being during adolescence. It may help develop better support for young people.
Singapore, SingaporeAges 13–15 - NCT06625593RecruitingPhase 1
Study of BG-C137 for advanced solid tumors
This trial tests a new drug called BG-C137 for people with advanced solid tumors that have stopped responding to other treatments. The drug targets a protein called FGFR2b found on some cancer cells, aiming to deliver a therapy directly to the tumor.
Los Angeles, CaliforniaAges 18 years+ - NCT06610773RecruitingPhase 1/Phase 2
Stem cell treatment for high-risk HPV infection
This trial tests whether umbilical cord stem cells can help clear a persistent high-risk HPV infection. It is for women aged 25 to 60 who have had HPV for a while and have not been treated with other HPV drugs recently.
Shanghai, Shanghai MunicipalityAges 25–60 - NCT06599697RecruitingPhase 2
IVIG for anti-HMGCR muscle disease
This trial tests if IVIG (intravenous immunoglobulin, a donated blood product that helps the immune system) can improve muscle strength and reduce damage in people with anti-HMGCR immune-mediated necrotizing myopathy (a rare muscle disease where the immune system attacks muscle cells). It may help you if your muscle weakness is not too severe and you haven't tried IVIG before.
Birmingham, AlabamaAges 16 years+ - NCT06603844RecruitingPhase 1/Phase 2
Study of CRB-601-01 for advanced solid tumors
This study tests a new drug, CRB-601-01, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and can help shrink tumors.
Birmingham, AlabamaAges 18 years+ - NCT05668403RecruitingPhase 1
Subcutaneous anti-CD20 antibody for primary membranous nephropathy
This Phase 1 study tests a skin-under-the-bone (subcutaneous) antibody medicine that targets CD20 on certain immune cells. It aims to see safety and how the drug may work in people with primary membranous nephropathy, a kidney disease that can cause high urine protein.
Zhengzhou, He'nanAges 18–75 - NCT07396181Recruiting
Standardizing embryo transfer conditions for IVF
This study compares different methods for transferring frozen embryos into the uterus during IVF. It aims to find the best technique to improve pregnancy chances.
WarsawAges 18–38
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,243 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.